- Role of single nucleotide polymorphisms of the HSD3B1 gene (rs6203 and rs33937873) in the prediction of prostate cancer riskless than 1 hour agoRead
- The evolving clinical use of prostate cancer biomarkers5 hours agoRead
- Optimizing anti-androgen treatment use among men with pathologic lymph-node positive prostate cancer treated with radical prostatectomy: the importance of postoperative PSA kinetics5 hours agoRead
- MTA1: a vital modulator in prostate cancer6 hours agoRead
- Gene Expression Analysis Reveals Prognostic Biomarkers of the Tyrosine Metabolism Reprogramming Pathway for Prostate Cancer7 hours agoRead
- FOXP2 confers oncogenic effects in prostate cancer through activating MET signalling21 hours agoRead
- Clinical Efficacy and Psychological Impact of Omaha-Based Continuing Care for Prostate Cancer Patients1 day agoRead
- LMX1B Activated Circular RNA GFRA1 Modulates the Tumorigenic Properties and Immune Escape of Prostate Cancer2 days agoRead
- Cells, Vol. 11, Pages 2118: Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer2 days agoRead
- Cells, Vol. 11, Pages 2118: Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer2 days agoRead
- Modulating Tumour Hypoxia in Prostate Cancer Through Exercise: The Impact of Redox Signalling on Radiosensitivity89 days agoRead
- LMX1B Activated Circular RNA GFRA1 Modulates the Tumorigenic Properties and Immune Escape of Prostate Cancer2 days agoRead
- Biomedicines, Vol. 10, Pages 882: 68Ga-PSMA-11 PET/CT Initial Staging in Black and White South African Males with ISUP Grade Group 1 and 2 Prostate Adenocarcinoma86 days agoRead
- GreenLight photovaporization of the prostate in high-medical-risk patients: an analysis of the Global GreenLight Group (GGG) database99 days agoRead
- Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score143 days agoRead
- Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy595 days agoRead
- Prostate Cancer Risk Stratification via Nondestructive 3D Pathology with Deep Learning-Assisted Gland Analysis170 days agoRead
- Prostate cancer prognosis after initiation of androgen deprivation therapy among statin users. A population-based cohort study141 days agoRead
- Prostate Cancer–specific Survival After Radical Prostatectomy Is Improved Among Metformin Users but Not Among Other Antidiabetic Drug Users139 days agoRead
- Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy682 days agoRead
- Prostate cancer risk prediction using a polygenic risk score597 days agoRead
- Prostate-specific membrane antigen expression in the vasculature of primary lung carcinomas associates with faster metastatic dissemination to the brain674 days agoRead
- Prostate specific antigen for early detection of prostate cancer: longitudinal study.4667 days agoRead
- Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease.3173 days agoRead
- Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease.3173 days agoRead
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial.4718 days agoRead
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial.4717 days agoRead
- Prostate Cancer Mortality Reduction by Prostate-Specific Antigen-Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC).4715 days agoRead
- Prostate Cancer Mortality Reduction by Prostate-Specific Antigen-Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC).4715 days agoRead
- Prostate Cancer Mortality Reduction by Prostate-Specific Antigen-Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC).4715 days agoRead
- Prostate cancer and PSA among statin users in the finnish prostate cancer screening trial.4556 days agoRead
- Prostate cancer and PSA among statin users in the finnish prostate cancer screening trial.4556 days agoRead
- Prostate-cancer mortality at 11 years of follow-up.3765 days agoRead
- Prostate-cancer mortality at 11 years of follow-up.3765 days agoRead
- Prostate-cancer mortality at 11 years of follow-up.3765 days agoRead
- HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).3551 days agoRead
- HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).3551 days agoRead
- Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.3387 days agoRead
- Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.3387 days agoRead
- Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.3386 days agoRead
- Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.3334 days agoRead
- Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial.2917 days agoRead
- Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial.2917 days agoRead
- Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial.2917 days agoRead
- Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial.2919 days agoRead
- A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.2852 days agoRead
- A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.2851 days agoRead
- A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.2851 days agoRead
- A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.2851 days agoRead
- A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.2851 days agoRead
- Medicine - All Feeds
- Allergology and Immunology
- Anatomy and Physiology
- Anesthesiology and Intensive Care
- Biochemistry
- Bioengineering
- Biophysics
- Biotechnology
- Cardiology
- Cardiothoracic Surgery
- Clinical Chemistry
- Clinical Medicine
- Complementary Medicine
- Cytology and Histology
- Dentistry
- Dermatology
- Endocrinology
- Forensic Medicine
- Gastroenterology
- General Practice
- Genetics
- Geriatrics
- Health services and Administration
- Hematology
- Infectious Diseases
- Internal Medicine
- Logopedics
- Medical Education and Humanities
- Medical Microbiology
- Medicine - Other
- Nephrology
- Neurology
- Neurosurgery
- Nursing
- Nutritional Sciences
- Obstetrics and Gynecology
- Occupational Health
- Oncology
- Ophthalmology
- Oral and Maxillofacial Surgery
- Orthopedics and Traumatology
- Otorhinolaryngology and Phoniatrics
- Pathology
- Pediatrics
- Pharmacology and Pharmacotherapy
- Physical and Rehabilitation Medicine
- Plastic Surgery
- Psychiatry
- Psychology
- Public Health
- Radiology
- Respiratory Medicine
- Rheumatology
- Sports Medicine
- Surgery
- Urology